Dr Christine Mordstein has more than 15 years of experience in RNA synthetic biology. Her expertise spans gene expression regulation, xRNA design, and the discovery and development of xRNA-based therapeutics and vaccines. 

She has led Centillion’s Biofoundry since 2024, with responsibilities spanning RNA process development, manufacturing and technology transfer. Christine holds a PhD in Molecular Medicine from the University of Edinburgh and is a member of the RNA Society and the Society for RNA Therapeutics.